Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Antonia Maloney"'
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Background: 5-fluorouracil (5-FU) and mitomycin-C (MMC) with radiotherapy (RT) remain an established treatment for patients with anal cancer (AC). Genetic mutations in two major metabolizing enzymes for 5-FU; dihydropyrimidine dehydrogenase ( DPYD an
Externí odkaz:
https://doaj.org/article/ba7acc6448b74d499ff17f2ca21ba609
Autor:
Mingqian Lin, Douglas Hackenyos, Fengqing Wang, Nicole Savidge, Angela Wimmer, Antonia Maloney, Susan Mohebbi, Michele Guard, Susan K. Parsons
Publikováno v:
Broadly Engaged Team Science in Clinical and Translational Research ISBN: 9783030830274
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd365291eb18802866e76ba83428e3d1
https://doi.org/10.1007/978-3-030-83028-1_19
https://doi.org/10.1007/978-3-030-83028-1_19
Publikováno v:
Cancer Med J
BACKGROUND: Most common sites of metastases in patients with colorectal cancer (CRC) include liver and lung. Brain metastases are very rare but their presence is associated with a poor prognosis and shorter survival. We report our investigation into
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e4ba49d58c8e74347e87ecee2c226ccc
https://pubmed.ncbi.nlm.nih.gov/32577630
https://pubmed.ncbi.nlm.nih.gov/32577630
Publikováno v:
Therapeutic Advances in Gastroenterology
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Background: 5-fluorouracil (5-FU) and mitomycin-C (MMC) with radiotherapy (RT) remain an established treatment for patients with anal cancer (AC). Genetic mutations in two major metabolizing enzymes for 5-FU; dihydropyrimidine dehydrogenase ( DPYD an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcf2daf9d733058af849b26b4e316a1a
https://doi.org/10.1177/17562848211024464
https://doi.org/10.1177/17562848211024464
Publikováno v:
Annals of Gastroenterology : Quarterly Publication of the Hellenic Society of Gastroenterology
Imatinib, an orally administered protein-tyrosine kinase inhibitor (TKI) is indicated for the treatment of chronic myeloid leukemia (CML) and gastrointestinal stromal tumor (GIST). Severe hepatotoxicity associated with imatinib is rare, and relations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c90ec14a85be903d112a11fe3b3cd93b
http://europepmc.org/articles/PMC5049570
http://europepmc.org/articles/PMC5049570
Autor:
Nausheen Hakim, Antonia Maloney, Jyothi Jose, Linda Moriarty, Wasif M. Saif, Jeffrey Chi, Danielle K. DePeralta, Gary B. Deutsch, Melissa H Smith, Sandeep Anantha, Arvind Rishi, Hasan Rehman, Elliot Newman, Gene F. Coppa, William Nealon
Publikováno v:
Journal of Clinical Oncology. 38:4628-4628
4628 Background: ESPAC-4 study showed that GemCap conferred a survival benefit over gemcitabine monotherapy in resected PC patients. ESPAC-4 included patients with median age of 65 years (37-81) and ECOG performance status (PS) of 0 (43%), 1 (54%) an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a2d5ba1dd8dfe22750aad6796b85f4f
https://doi.org/10.1200/jco.2020.38.15_suppl.4628
https://doi.org/10.1200/jco.2020.38.15_suppl.4628
Publikováno v:
Cancer chemotherapy and pharmacology. 80(2)
MPACT demonstrated a survival benefit of nab-paclitaxel plus gemcitabine versus gemcitabine in advanced pancreatic cancer (APC). However, sensory peripheral neuropathy is a dose-limiting toxicity and neuromodulators have shown limited, if any activit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dde1d68fb8136b75cb1a40eb08aac4d
https://pubmed.ncbi.nlm.nih.gov/28664225
https://pubmed.ncbi.nlm.nih.gov/28664225
Publikováno v:
Journal of Clinical Oncology. 37:e15023-e15023
e15023 Background: CRC, the third most common cancer in the United States, carries racial/ethnic disparities in both incidence and mortality. With availability of effective systemic therapies, the life of CRC patients can be prolonged which thereby i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd22f0f0a9058d77ec68056c24900dd3
https://doi.org/10.1200/jco.2019.37.15_suppl.e15023
https://doi.org/10.1200/jco.2019.37.15_suppl.e15023
Autor:
Ruchi Hamal, Wasif M. Saif, Nauman S Siddiqui, Antonia Maloney, Kathryn E. Huber, Lilian Chen
Publikováno v:
Journal of Clinical Oncology. 37:605-605
605 Background: 5-FU and mitomycin-C (MMC) with radiotherapy (RT) remain an established treatment for pts with LA (T2-4, N0-1, M0 or T1-4, N2-3, M0) AC. Genetic mutations in 2 major metabolizing enzymes for 5-FU; DPYD and TYMS have been associated wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7fb11af1b5ef4df9d3c1aae54d716286
https://doi.org/10.1200/jco.2019.37.4_suppl.605
https://doi.org/10.1200/jco.2019.37.4_suppl.605
Autor:
Martin D. Goodman, Valerie Relias, Sanjay Hegde, Douglas W Hackenyos, Antonia Maloney, Melissa H Smith, Wasif M. Saif, Lisa Ralph
Publikováno v:
Journal of Clinical Oncology. 34:e15672-e15672
e15672Background: MPACT study showed survival benefit of nab-gem vs. gem in APC [Von Hoff D, NEJM 2013]. Sensory peripheral neuropathy is a dose-limiting toxicity associated with nab. Neuromodulato...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6135d732037af8624fd9b39b2843390a
https://doi.org/10.1200/jco.2016.34.15_suppl.e15672
https://doi.org/10.1200/jco.2016.34.15_suppl.e15672